This is the reason why paroxetine-mediated direct inhibition of GRK2 has been reported to be fruitful in mice studies for improving osteoarthritis, cardiac hypertrophy, myocardial infarction, and heart failure (4–8). Here, GRK2 is linked to cardiac hypertrophy.